AstraZeneca (NASDAQ:AZN) used its presentation at the J.P. Morgan Healthcare Conference to highlight strong 2025 performance, ...
AstraZeneca (AZN) is one of the fast-growing pharmaceutical companies that has played a significant role in saving the lives of COVID-19 patients and is known worldwide for innovative medicines such ...
AstraZeneca had already bagged the rights to the AbelZeta Pharma-partnered CAR-T cell therapy for most of the world. | The ...
The company is embracing AI integration throughout drug development, aiming to improve efficiency and drive portfolio ...
Pascal Soriot, Chief Executive Officer, AstraZeneca, said: "Our strong growth momentum has continued into 2025 and we have now entered an unprecedented catalyst-rich period for our company. Already ...
By Maggie Fick SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on ...
January 2026 AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock ExchangeTicker symbol for ordinary shares will remain AZN AstraZeneca PLC ("Astr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results